Clene Inc. Common Stock
Symbol: CLNN (NASDAQ)
6.43
▼ (-0.70%) -0.045
Company Description:
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Key Stats
- Today's Open: $6.56
- Today's High: $6.825
- Today's Low: $6.315
- Today's Volume: 48.57K
- Yesterday Close: $6.47
- Yesterday High: $6.6303
- Yesterday Low: $6.1801
- Yesterday Volume: 97.18K
- Last Min Volume: 0
- Last Min High: $6.424
- Last Min Low: $6.424
- Last Min VWAP: $0
Company Profile
- Name: Clene Inc. Common Stock
- Website: https://www.clene.com
- Listed Date: 2020-12-31
- Location: SALT LAKE CITY, UT
- Market Status: Active
- CIK Number: 0001822791
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $64.64M
- Round Lot: 100
- Outstanding Shares: 9.99M
- Asset Type: CS
RECENT FILINGS FOR CLNN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 8-K | View |
| 2025-09-05 | 424B5 | View |
| 2025-09-05 | S-3 | View |
| 2025-09-05 | S-8 | View |
| 2025-08-21 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | 4 | View |
| 2025-08-14 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-03 | 8-K | View |
| 2025-07-03 | 424B5 | View |
| 2025-06-30 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-04 | 4 | View |
Latest News on CLNN